Table 1.

Patient reported outcomes before March, in June and in November 2020 in patients with IRD. N=7,836

Before*June 2020Nov 2020
Patient VAS global, mm30 (12-58)28 (10-54)29 (10-55)
Patient VAS pain, mm27 (11-51)28 (11-51)29 (11-52)
HAQ0.50 (0.13-1.0)0.50 (0.13-1.00)0.50 (0.13-1.00)
EQ-5D0.80 (0.72-0.86)0.79 (0.71-0.86)0.80 (0.71-0.86)
PASS, yes73%75%76%
  • Numbers are median (IQR) unless otherwise stated*Latest registration in DANBIO before March 2020Patient characteristics for RA/AxSpA/PsA/Other: female, %: 70/53/44/69. Age, years, median(IQR): 67(59-74)/62(54-69)/56(46-65)/59(50-68)Abbreviations: EQ-5D: Quality of life, 5 dimensions, HAQ: health assessment questionnaire, PASS: patient acceptable symptom state, VAS: visual analogue scale